🚨 The text mentions transient hair loss (telogen effluvium) as a symptom, which is relevant to hair loss and human biology related to hair, but the primary focus is on MIS-C and COVID-19 vaccination effects.
TLDR COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.
This case report and literature review discuss a 6-year-old girl who developed severe multisystem inflammatory syndrome in children (MIS-C) 30 days after receiving her second dose of the COVID-19 vaccine, despite no prior detected SARS-CoV-2 infection. She presented with fever, abdominal pain, rash, and other symptoms, and was diagnosed with MIS-C through positive anti-SARS-CoV-2 antibodies. Treatment with intravenous immunoglobulins and methylprednisone led to initial improvement, but she later developed pancreatitis and severe neurological symptoms, which resolved after 2 months. She also experienced transient hair loss (telogen effluvium) 3 months post-symptom onset. After 12 months, she showed no symptomatic sequelae. The case suggests a potential link between COVID-19 vaccination and MIS-C in young children and underscores the importance of prompt diagnosis and treatment.
12 citations
,
July 2022 in “Journal of Cosmetic Dermatology” COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
7 citations
,
May 2022 in “The Journal of Dermatology” Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.
2 citations
,
February 2021 in “The Pediatric Infectious Disease Journal” Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.
28 citations
,
January 2021 in “Skin appendage disorders” COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.
58 citations
,
November 2020 in “International Journal of Dermatology” COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
24 citations
,
January 2015 in “Current problems in dermatology” The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.
2 citations
,
February 2021 in “The Pediatric Infectious Disease Journal” Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.
January 2018 in “Przegla̧d dermatologiczny” The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.
34 citations
,
June 2014 in “The BMJ” Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.
273 citations
,
May 2017 in “The Lancet” Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.
9 citations
,
August 2002 in “Current Opinion in Pediatrics” An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.
